AI assistant
ABBOTT LABORATORIES — Director's Dealing 2015
Feb 24, 2015
29777_rns_2015-02-24_5c79254f-5e02-4bd5-ad2b-3eac3171d04a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
SEC FORM 4 Page 1 of 1
SEC Form 4
FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
| OMB APPROVAL | ||
|---|---|---|
| OMB Number: | 3235-0287 | |
| Expires: | December 31, 2014 | |
| Estimated average burden hours per response: | 0.5 | |
| 1. Name and Address of Reporting Person Fussell Stephen R | ||
| --- | --- | --- |
| (Last) (First) (Middle) 100 ABBOTT PARK ROAD | ||
| (Street) ABBOTT PARK IL 60064-6400 | ||
| (City) (State) (Zip) | ||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) |
| Common shares without par value | 02/20/2015 | |
| Common shares without par value | ||
| Common shares without par value | ||
| Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | ||
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) |
| Option (right to buy) (4) | $47 | 02/20/2015 |
Explanation of Responses:
- These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- Balance in the Abbott Laboratories Stock Retirement Trust as of February 20, 2015.
- The reporting person disclaims beneficial ownership of all securities held by his spouse.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 56,409 on 2/20/16, 56,409 on 2/20/17, and 56,409 on 2/20/18.
John A. Berry, by power of attorney for Stephen R. Fussell
02/24/2015
** Signature of Reporting Person
Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
- If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
http://www.sec.gov/Archives/edgar/data/1800/000117911015003339/xslF345X03/edgar.xml 2/24/2015